An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States
Milev, Sandra, DiBonaventura, Marco daCosta, Quon, Peter, Goh, Jo Wern, Bourret, Jeffrey, Peeples-Lamirande, Kathleen, Soonasra, Arif, Cappelleri, Joseph C., Quirk, DanielLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2019.1609481
Date:
April, 2019
File:
PDF, 923 KB
english, 2019